A Phase 3b, multicenter, randomized, double blind, Placebo-controlled, parallel-group trial with an open label extension phase to evaluate efficacy and safety of avatrombopag for the treatmnet of trombocytopenia in pediatric subject with immune trombocytopenia for > 6 months


Karakaş Z. (Executive), Tanyıldız H. G.

Other International Funding Programs, 2021 - 2023

  • Project Type: Other International Funding Programs
  • Begin Date: July 2021
  • End Date: August 2023